Scientists are explaining that antibody production doesn't stop, it simply plateaus - in some people, COVID antibodies exist "11 months after first symptoms".
The idea is still at an early stage, but initial clinical study results show that immunotherapy against type 1 diabetes could function as a 'diabetes vaccine.'
Scientists at the University of Nottingham are exploring the potential of new treatment for epilepsy, as they reveal that neuron connections in the brain can be a good indicator of disease progression.
Sarah-Jane McQueen, General Manager of the online healthcare course comparison website at CoursesOnline explains how health workers can find the time to focus on their learning & development in this special skills focus.
According to a new analysis by researchers, ethnic minorities in the US experienced disproportionately high levels of cardiac deaths during the pandemic - in comparison to the rates in 2019.
The REACT study suggests that scientists don't know if the Indian variant is more infectious than the Kent variant - largely responsible for the winter wave of deaths.
Bernard Ross, CEO of Sky Medical Technology, looks at how wearable medical technology can address some of the most critical medical issues of the 21st Century.
Scientists examining how COVID impacts the entire human body, not just the lungs, believe that there could be a link between the endothelium and Long COVID.
Senior Researcher in Social Science Michael Morrison explains why disruptive technologies need institutional and systemic readiness to truly realise the benefits of healthcare innovation.
On Wednesday (12 May), the CDC announced that the Pfizer vaccine could now be given to 12-15 year olds - effective immediately for 17 million adolescents.
